Systemic manifestations such as gynecomastia can be caused by beta-hCG; therefore, assaying serum beta-HCG, AFP, and LDH is essential to preventing diagnostic delay of a GCT in patients presenting with extra-gonadal symptoms [2]. The gene discussed is AFP; the disease is granular cell tumor.